Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Z-360 MeSH Supplementary Concept Data 2025


MeSH Supplementary
Z-360
Unique ID
C528831
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C528831
Entry Term(s)
calcium bis((R)-(-)-3-(3-(5-cyclohexyl-1-(3,3-dimethyl-2-oxo-butyl)-2-oxo-2,3,4,5-tetrahydro-1H-benzo(b)(1,4)diazepin-3-yl)ureido)benzoate)
Registry Numbers
0
Heading Mapped to
*Benzodiazepinones
Frequency
12
Note
an orally-active CCK-2R antagonist for treatment of gastrointestinal cancer models; structure in first source
Source
Regul Pept 2008 Feb 7;146(1-3):46-57
Date of Entry
2008/05/14
Revision Date
2008/05/14
Z-360 Preferred
calcium bis((R)-(-)-3-(3-(5-cyclohexyl-1-(3,3-dimethyl-2-oxo-butyl)-2-oxo-2,3,4,5-tetrahydro-1H-benzo(b)(1,4)diazepin-3-yl)ureido)benzoate) Broader
page delivered in 0.005s